TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33797734

Group type: EXPERIMENTAL
Intervention: End-to-end pancreatic anastomosis
Number of subjects: 74

Group type: COMPARATOR
Intervention: Pancreaticojejunostomy
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 74
Study: 33140719

Group type: EXPERIMENTAL
Intervention: Robot‐assisted training
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy
Number of subjects: 770

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 770
Study: 35109577

Group type: EXPERIMENTAL
Intervention: NeuronUP-tDCS
Number of subjects: 53

Group type: COMPARATOR
Intervention: NeuronUP-Sham
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Videogame-tDCS
Number of subjects: 53

Group type: COMPARATOR
Intervention: Videogame-Sham
Number of subjects: 53

Group type: COMPARATOR
Intervention: Active-control
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Overall Prospective Memory
Number of subjects: 53
Study: 32224082

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) 1 g intravenously preoperatively
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 34499328

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) tool
Number of subjects: 350

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 350
Study: 34732509

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5560

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5560
Study: 35130054

Group type: EXPERIMENTAL
Intervention: 1 g acetaminophen 4× daily
Number of subjects: 110

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 110
Study: 33812367

Group type: EXPERIMENTAL
Intervention: Likelihood Ratio Test (LRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wald tests with the between-within DF method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wald tests with the Satterthwaite DF approximation
Number of subjects: 0
Study: 35806943

Group type: EXPERIMENTAL
Intervention: Text-based format
Number of subjects: 500

Group type: COMPARATOR
Intervention: Graphical format
Number of subjects: 500
Study: 33200428

Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 271
Study: 35912427

Group type: EXPERIMENTAL
Intervention: Ramped position
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sniffing position
Number of subjects: 82
Study: 34971331

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation of the rectus femoris and gastrocnemius muscles bilaterally, applied for 60 min, twice a day for up to 10 sessions until postoperative day 5.
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional physiotherapy (Control group)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 88
Study: 35801802

Group type: EXPERIMENTAL
Intervention: Nomogram models for predicting lung metastasis (LM) incidence
Number of subjects: 10929

Group type: EXPERIMENTAL
Intervention: Nomogram models for evaluating overall survival (OS)
Number of subjects: 10929

Group type: EXPERIMENTAL
Intervention: Nomogram models for evaluating cancer-specific survival (CSS)
Number of subjects: 10929
Study: 33763938

Group type: EXPERIMENTAL
Intervention: Intramuscular ketamine
Number of subjects: 358
Study: 33832142

Group type: EXPERIMENTAL
Intervention: FMS training 4 times per week for 12 weeks
Number of subjects: 71
Study: 33879221

Group type: EXPERIMENTAL
Intervention: Acupotomy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Sham acupotomy
Number of subjects: 136
Study: 32096830

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen alternating with noninvasive ventilation
Number of subjects: 88

Group type: COMPARATOR
Intervention: High-flow nasal oxygen alone
Number of subjects: 88
Study: 35590297

Group type: EXPERIMENTAL
Intervention: Intracavitary electrocardiogram (ECG) guidance
Number of subjects: 436

Group type: COMPARATOR
Intervention: Chest computed tomography (CT)
Number of subjects: 436
Study: 33351982

Group type: EXPERIMENTAL
Intervention: Oral azacitidine maintenance therapy
Number of subjects: 0
Study: 32627354

Group type: EXPERIMENTAL
Intervention: Plasma ceramide levels (Cer(d18:1/16:0), Cer(d18:1/24:1))
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Plasma ratios of ceramides with Cer(d18:1/24:0)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Adjusted plasma ratios of ceramides with Cer(d18:1/24:0)
Number of subjects: 200
Study: 34751784

Group type: EXPERIMENTAL
Intervention: Hip-focused treatment
Number of subjects: 180

Group type: COMPARATOR
Intervention: Spine-focused treatment
Number of subjects: 180
Study: 35428621

Group type: EXPERIMENTAL
Intervention: Prostate biopsies post-MRI based on individualised risk estimation and shared decision-making
Number of subjects: 830

Group type: COMPARATOR
Intervention: Prostate biopsies post-MRI for all men
Number of subjects: 830
Study: 35182115

Group type: EXPERIMENTAL
Intervention: Treatment and prevention complex
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ultraphonophoresis with placebo
Number of subjects: 90
Study: 33214094

Group type: EXPERIMENTAL
Intervention: Desflurane-nitrous oxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Desflurane alone
Number of subjects: 0
Study: 33350370

Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg single dose)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study: 35698156

Group type: EXPERIMENTAL
Intervention: Smartphone app-based health care intervention for health management (6 weeks duration)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group receiving health management information on paper
Number of subjects: 500
Study: 34514614

Group type: COMPARATOR
Intervention: Remifentanil plasma target concentration of 0 ng/ml (group R0)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remifentanil plasma target concentration of 1 ng/ml (group R1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remifentanil plasma target concentration of 2 ng/ml (group R2)
Number of subjects: 75
Study: 36194619

Group type: EXPERIMENTAL
Intervention: Oral Qurs‐e‐Asfar (QA) 778 mg twice a day and topical Rogan‐e‐Narjeel (RN)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Oral Itraconazole (100 mg/day) and topical Terbinafine hydrochloride (1%)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study: 34710784

Group type: EXPERIMENTAL
Intervention: Sildenafil orally disintegrating strips
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sildenafil tablets
Number of subjects: 120
Study: 35848451

Group type: EXPERIMENTAL
Intervention: Paravertebral Block (PVB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Mid-Point Transverse Process Pleura Block (MTP)
Number of subjects: 64
Study: 33509742

Group type: EXPERIMENTAL
Intervention: Curcumin gel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Curcumin mucoadhesive patches
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 36036079

Group type: EXPERIMENTAL
Intervention: Personalised 3D-printed osteotomy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional osteotomy
Number of subjects: 22
Study: 34535714

Group type: EXPERIMENTAL
Intervention: Dance intervention (DI) for 6 months
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Dance intervention (DI)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Cognitive reserve (CR)
Number of subjects: 99
Study: 34789394

Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2 every 3 wk × 4 cycles)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 wk × 4 cycles)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: No specific intervention
Number of subjects: 195
Study: 35098012

Group type: EXPERIMENTAL
Intervention: PERMA intervention
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: IBCT intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Infertility treatment training program (Control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 42
Study: 35617841

Group type: EXPERIMENTAL
Intervention: Twice-daily hypertonic saline irrigation for 6 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Twice-daily saline/xylitol irrigation for 6 weeks
Number of subjects: 125
Study: 32737844

Group type: EXPERIMENTAL
Intervention: Phase II trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phase III trials
Number of subjects: 0
Study: 32407786

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate cloths (Sage 2%) applied the night before and the morning of scheduled cesarean delivery.
Number of subjects: 1356

Group type: COMPARATOR
Intervention: Placebo cloths (Sage Comfort Bath fragrance-free) applied the night before and the morning of scheduled cesarean delivery.
Number of subjects: 1356
Study: 33446035

Group type: EXPERIMENTAL
Intervention: Web-based education
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 260
Study: 34516169

Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (target BAC = .08%)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Nonalcoholic control beverage
Number of subjects: 246
Study: 32349693

Group type: EXPERIMENTAL
Intervention: SIP SMART intervention (two 45-min consultations including baseline clinical and instrumental swallowing assessment, educational information, targeted swallowing exercises, behaviour change strategies)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SIP SMART intervention
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MD Anderson Dysphagia Inventory
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care (single session including baseline clinical assessment and generic information)
Number of subjects: 32
Study: 36245363

Group type: EXPERIMENTAL
Intervention: Remote patient monitoring (RPM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-clinic follow-up
Number of subjects: 0
Study: 34918029

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 33163057

Group type: EXPERIMENTAL
Intervention: Weight reduction program (group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 80
Study: 36442225

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training at 30 Hz
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training at 45 Hz
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (general)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 33705169

Group type: EXPERIMENTAL
Intervention: DESTRESS-WV (online, coach-assisted cognitive behavioral intervention)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Phone monitoring only (control)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: DESTRESS-WV
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both treatments (DESTRESS-WV and phone monitoring)
Number of subjects: 102
Study: 32134712

Group type: EXPERIMENTAL
Intervention: Morning exercise at 60% V̇o2max for 1 hour
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Afternoon exercise at 60% V̇o2max for 1 hour
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 11
Study: 34607768

Group type: EXPERIMENTAL
Intervention: Contact Lenses (CL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Spectacles (Sp)
Number of subjects: 30
Study: 33368858

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 35132749

Group type: EXPERIMENTAL
Intervention: Mentalisation-based treatment (MBT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard clinical management (control)
Number of subjects: 32
Study: 34127509

Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT)
Number of subjects: 899

Group type: EXPERIMENTAL
Intervention: Blood DNA test
Number of subjects: 899

Group type: EXPERIMENTAL
Intervention: Choice of either test (FIT or blood test)
Number of subjects: 899

Group type: EXPERIMENTAL
Intervention: Fecal test within choice group
Number of subjects: 899

Group type: EXPERIMENTAL
Intervention: Blood test within choice group
Number of subjects: 899
Study: 36268543

Group type: EXPERIMENTAL
Intervention: Internet-based writing intervention (6 weeks, six structured writing assignments based on cognitive behavioral therapy)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Internet-based writing intervention
Number of subjects: 86
Study: 32876107

Group type: EXPERIMENTAL
Intervention: Bone Mineral Density (BMD)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Texture Attributes (TAs)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Interobserver Agreement
Number of subjects: 49
Study: 34825283

Group type: EXPERIMENTAL
Intervention: Preoperative prophylactic antibiotics
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control (no preoperative prophylactic antibiotics)
Number of subjects: 312
Study: 35087846

Group type: EXPERIMENTAL
Intervention: Yijinjing Qigong Exercise (YJJQE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stretching training exercise (STE)
Number of subjects: 50
Study: 36420685

Group type: EXPERIMENTAL
Intervention: Laparoscopic-enclosed electromechanical morcellation (LEM)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Vaginal-enclosed scalpel morcellation (VSM)
Number of subjects: 118
Study: 32862425

Group type: EXPERIMENTAL
Intervention: Supervised group exercise (12 weeks, twice weekly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supervised group exercise (per protocol analysis, ≥75% attendance)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supervised group exercise (8 weeks postpartum)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36808268

Group type: EXPERIMENTAL
Intervention: Rimegepant 75 mg ODT
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 34618162

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study: 36891452

Group type: EXPERIMENTAL
Intervention: PECs II block with 25 ml of 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no PECs II block)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PECs II block
Number of subjects: 60
Study: 34288696

Group type: EXPERIMENTAL
Intervention: 6 months of FOLFIRINOX (arm A)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: 4 months of FOLFIRINOX followed by leucovorin plus fluorouracil maintenance treatment (arm B)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Sequential treatment alternating gemcitabine and fluorouracil, leucovorin, and irinotecan every 2 months (arm C)
Number of subjects: 276
Study: 32441655

Group type: EXPERIMENTAL
Intervention: Blended learning involving traditional lectures plus m-learning via the iPOT app
Number of subjects: 99

Group type: COMPARATOR
Intervention: Traditional on-site learning
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Frequent users of the iPOT app
Number of subjects: 99
Study: 35076797

Group type: EXPERIMENTAL
Intervention: PrEP taken by daily pill
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: PrEP by injection
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: PrEP by pill
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Other PrEP modalities (event-based pill, anal suppository, gel, condoms)
Number of subjects: 694
Study: 32246765

Group type: EXPERIMENTAL
Intervention: GM-CSF (intrauterine infusion)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control (gel without GM-CSF)
Number of subjects: 304
Study: 35618335

Group type: EXPERIMENTAL
Intervention: AWARE intervention (360° multimodal intervention)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: AWARE intervention
Number of subjects: 120
Study: 33707989

Group type: EXPERIMENTAL
Intervention: Head cooling (HC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No cooling (CON)
Number of subjects: 10
Study: 34709134

Group type: EXPERIMENTAL
Intervention: Low-intensity plyometric training for 7 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 33392842

Group type: EXPERIMENTAL
Intervention: DE-assisted wide local excision
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard wide local excision (no-DE)
Number of subjects: 78
Study: 35343901

Group type: EXPERIMENTAL
Intervention: High level of effort for behavioral adherence
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Moderate level of effort for attitudinal adherence
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Adherence measures in initiators-only sample
Number of subjects: 947
Study: 34563097

Group type: EXPERIMENTAL
Intervention: Human recombinant epidermal growth factor (h‐EGF) in 2% carboxymethyl cellulose gel
Number of subjects: 25

Group type: COMPARATOR
Intervention: 2% carboxymethyl cellulose gel (control)
Number of subjects: 25
Study: 34654942

Group type: EXPERIMENTAL
Intervention: GI-0.025 mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GII-0.05 mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GIII-0.10 mL
Number of subjects: 30
Study: 34147439

Group type: EXPERIMENTAL
Intervention: Coronary CTA-guided group (n=200)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Angiography-guided group (n=200)
Number of subjects: 400
Study: 32243582

Group type: EXPERIMENTAL
Intervention: Paroxetine (5-HT reuptake inhibitor)
Number of subjects: 15
Study: 35322316

Group type: EXPERIMENTAL
Intervention: Air-abrasive powder
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Plasma cleaning
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electrolytic cleaning - Potassium Iodide (KI)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electrolytic cleaning - Sodium Formate (CHNaO2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 60
Study: 35758427

Group type: EXPERIMENTAL
Intervention: OpenSound Navigator (OSN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Omnidirectional algorithm (OMNI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both OSN and OMNI
Number of subjects: 40
Study: 34089660

Group type: EXPERIMENTAL
Intervention: rtCGM
Number of subjects: 254

Group type: COMPARATOR
Intervention: isCGM
Number of subjects: 254
Study: 35234868

Group type: EXPERIMENTAL
Intervention: mRNA‐1273
Number of subjects: 412

Group type: COMPARATOR
Intervention: BNT162b2
Number of subjects: 412

Group type: COMPARATOR
Intervention: SOTR
Number of subjects: 412
Study: 32039955

Group type: EXPERIMENTAL
Intervention: Kinematic alignment
Number of subjects: 99

Group type: COMPARATOR
Intervention: Mechanical alignment
Number of subjects: 99
Study: 2011535125

Group type: EXPERIMENTAL
Intervention: Pedimed cream
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 34532818

Group type: EXPERIMENTAL
Intervention: Phacoemulsification technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manual small incision cataract surgery (MSICS) technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal cataract cases (G1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complex cataract cases (G2 and G3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall complication rate
Number of subjects: 0
Study: 34735098

Group type: EXPERIMENTAL
Intervention: Bupropion (150-300 mg/d)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 32573927

Group type: EXPERIMENTAL
Intervention: Exenatide ER 2 mcg weekly
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 35649190

Group type: EXPERIMENTAL
Intervention: Cold-water hydrotherapy (Kneipp arm affusions) over 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 33839209

Group type: EXPERIMENTAL
Intervention: Combined Cognitive Reappraisal (CCR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Suppression
Number of subjects: 100
Study: 35490395

Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI) 2-4 mg
Number of subjects: 2531

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI) 2 mg
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI) 4 mg
Number of subjects: 2531
Study: 33864595

Group type: EXPERIMENTAL
Intervention: Male Partner Participation (MPP)
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Male Partner Involvement (MPI)
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Socio-demographic characteristics (educational attainment)
Number of subjects: 535
Study: 34385507

Group type: EXPERIMENTAL
Intervention: Valproic acid
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 34333143

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Erbium yttrium scandium gallium garnet (Er,Cr:YSGG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34118259

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane block (ESP) combined with spinal anesthesia (n=16)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Spinal anesthesia with morphine 1 mcg.kg-1 (n=15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Spinal anesthesia (control group, n=14)
Number of subjects: 45
Study: 34866163

Group type: EXPERIMENTAL
Intervention: Indirect bonded customized CAD/CAM brackets (Insignia™, Ormco, USA)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Direct bonded self‐ligating brackets (Damon, Ormco, USA)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: CAD/CAM group
Number of subjects: 38
Study: 36111620

Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE) and graded exposure
Number of subjects: 37

Group type: COMPARATOR
Intervention: Pilates and postural education
Number of subjects: 37
Study: 32107935

Group type: EXPERIMENTAL
Intervention: Group well-child care (GWCC)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Individual well-child care (IWCC)
Number of subjects: 97